Erratum to: A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study

Overview of attention for article published in BMC Cancer, June 2016

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 1,548 followers.

Erratum to: A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced... https://t.co/GRdYZfMzoF #cancer

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.